Life Sciences Nova Scotia
  • About
    • Who We Are
    • What we do
    • Why work in Nova Scotia?
    • Contact us
  • Members
    • Member Directory
    • Member Benefits
    • Become a member
  • Resources
    • Member Programs
    • News and success stories
    • PetriDish Job Board
  • Events
    • Events
    • BioPort Atlantic
    • Atlantic Precision Medicine Conference
  • Podcast
Select Page

BioTalent Canada and BioNova launch new provincial life sciences job board

by Shana Cristoferi | Feb 10, 2020 | BF2030, BioTalent Canada, News

HALIFAX, NS – February 10, 2020 – Today, BioTalent Canada and BioNova announced the launch of The PetriDish™ BioNova job board – giving companies in one of Canada’s fastest growing bio-economy hubs a platform to attract highly-skilled talent. According to BioTalent...

NEWS RELEASE – BioNova Announces Motryx as the Winner of the Ninth Annual BioInnovation Challenge (BIC) at BioPort 2019

by Shana Cristoferi | Nov 6, 2019 | MNP, Motryx, News

FOR IMMEDIATE RELEASE November 6, 2019 BioNova Announces Motryx as the Winner of the Ninth Annual BioInnovation Challenge (BIC) at BioPort 2019 Halifax, NS – November 6, 2019 – Today Motryx from Nova Scotia was named the winner of BioNova’s ninth annual BioInnovation...

Densitas Software Wins Procurement For DIMASOS Breast Screening Trial In Germany

by Shana Cristoferi | Sep 23, 2019 | Densitas Inc., News

See original news release here Announcing our densitas densityai™ software will be deployed in up to 24 clinics throughout Germany as part of a procurement for a major breast cancer screening trial. Our software will be used to provide breast density measurements at...

ENTREVESTOR: IMV Inc. entering a crucial phase in late 2019

by Shana Cristoferi | Sep 13, 2019 | News

Read original article here IMV Inc., the Dartmouth company developing a delivery platform for immunotherapy drugs, is entering a critical phase of its 16-year history as it will soon learn the results of key Phase 2 clinical trials. The company is conducting a range...

Mallinckrodt Agrees to Sell BioVectra Inc. to H.I.G. Capital for $250 Million

by Shana Cristoferi | Sep 11, 2019 | News

Read original news release here — Transaction continues to advance Mallinckrodt’s strategic focus on branded biopharmaceuticals by monetizing a non-core business — — H.I.G. Capital to support BioVectra leadership and its attractive growth plan...
« Older Entries
Next Entries »

Recent Posts

  • Manufacturing the Future of Life‑Saving Medicine in Nova Scotia
  • BIOTECanada Opens Canada Pavilion at BIO 2026 Amid Major Policy Momentum for Canadian Biotech
  • BioTalent Canada named among Canada’s Best Workplaces in Health Care (2026)
  • AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio
  • Nova Scotia’s Life Sciences, Biotech Sectors Highlighted at International Conference
No comments to show.
[buddybot_chat id=1]

Life Sciences Nova Scotia is the organization to help fuel your success.

Join today
  • WHO WE ARE
  • EVENTS
  • MEMBER PROGRAMS
  • CONTACT US
  • MEMBERS
  • NEWS & SUCCESS STORIES
  • Follow
  • Follow